ER degrader 3

• UNSPSC Description:

  ER degrader 3 is a potent degrader of estrogen receptor (ER). The estrogen signaling system plays an important role in regulating cell growth, differentiation and apoptosis. ER degrader 3 has the potential for the research of cancer diseases (extracted from patent WO2018233591A1, compound 1)[1].

• Target Antigen:

  Estrogen Receptor/ERR

• Type:

  Reference compound

• Related Pathways:

  Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/er-degrader-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  NCCCC[C@H](N)C(O)=O.C[C@H]1N(C2=CC=C(C3CC3)C=C2)[C@@](C4=CC=C(C=C4)/C=C/C(O)=O)([H])C5=CC=C(C6=CN(N=C6)CC)C=C5C1

• Molecular Weight:

  649.82

• References & Citations:

  [1]Lingfeng You, et al. A kind of salt of benzopiperidine derivatives, its crystal form and salt, the preparation method of its crystal form. Patent WO2018233591A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2254818-47-6